GlycoNex (ROCO:4168) Cyclically Adjusted Book per Share: NT$20.56 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4168 GlycoNex Inc ROCO:4168
56 GF Score
Price NT$23.95
GF Value NT$75.35
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is GlycoNex Cyclically Adjusted Book per Share?

GlycoNex ROCO:4168 -1.84% 56 Cyclically Adjusted Book per Share is NT$20.56 as of Dec. 2025. GuruFocus rates ROCO:4168 with a GF Score™ of 56/100 and a GF Value™ of NT$75.35 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

GlycoNex's adjusted book value per share for the three months ended in Dec. 2025 was NT$8.730. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$20.56 for the trailing ten years ended in Dec. 2025.

During the past 12 months, GlycoNex's average Cyclically Adjusted Book Growth Rate was -10.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -7.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of GlycoNex was 3.50% per year. The lowest was -7.30% per year. And the median was -2.30% per year.

As of today (2026-07-16), GlycoNex's current stock price is NT$23.95. GlycoNex's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$20.56. GlycoNex's Cyclically Adjusted PB Ratio of today is 1.16.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of GlycoNex was 1.72. The lowest was 0.73. And the median was 1.14.


GlycoNex  (ROCO:4168) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

GlycoNex's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=23.95/20.56
=1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of GlycoNex was 1.72. The lowest was 0.73. And the median was 1.14.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


GlycoNex Cyclically Adjusted Book per Share Related Terms


GlycoNex Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for GlycoNex's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlycoNex Cyclically Adjusted Book per Share Chart

GlycoNex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.51 25.83 25.03 22.87 20.56

GlycoNex Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.87 22.44 21.91 21.34 20.56

ROCO:4168 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, GlycoNex's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlycoNex Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GlycoNex's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where GlycoNex's Cyclically Adjusted PB Ratio falls into.


ROCO:4168
56GF Score
GlycoNex Inc ROCO:4168
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GlycoNex Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GlycoNex's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=8.73/324.0540*324.0540
=8.730

Current CPI (Dec. 2025) = 324.0540.

GlycoNex Quarterly Data

Book Value per Share CPI Adj_Book
201603 26.817 238.132 36.493
201606 26.376 241.018 35.463
201609 26.066 241.428 34.987
201612 25.568 241.432 34.318
201703 25.717 243.801 34.182
201706 25.203 244.955 33.341
201709 24.719 246.819 32.454
201712 24.150 246.524 31.745
201803 23.283 249.554 30.234
201806 21.998 251.989 28.289
201809 21.354 252.439 27.412
201812 20.051 251.233 25.863
201903 19.386 254.202 24.713
201906 18.334 256.143 23.195
201909 17.396 256.759 21.955
201912 16.992 256.974 21.428
202003 16.431 258.115 20.629
202006 18.295 257.797 22.997
202009 16.480 260.280 20.518
202012 15.726 260.474 19.565
202103 15.271 264.877 18.683
202106 14.790 271.696 17.640
202109 14.346 274.310 16.948
202112 13.880 278.802 16.133
202203 13.554 287.504 15.277
202206 13.425 296.311 14.682
202209 14.502 296.808 15.833
202212 13.465 296.797 14.702
202303 12.933 301.836 13.885
202306 12.922 305.109 13.724
202309 12.359 307.789 13.012
202312 11.767 306.746 12.431
202403 11.086 312.332 11.502
202406 10.659 314.175 10.994
202409 10.222 315.301 10.506
202412 9.647 315.605 9.905
202503 9.240 319.799 9.363
202506 9.191 322.561 9.234
202509 9.339 324.800 9.318
202512 8.730 324.054 8.730

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$20.56 mean?
GlycoNex (ROCO:4168) has a Cyclically Adjusted Book per Share of NT$20.56 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on GlycoNex and its competitors.
Is GlycoNex's Cyclically Adjusted Book per Share too high?
GlycoNex's current Cyclically Adjusted Book per Share is NT$20.56. Overall, GlycoNex has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GlycoNex's Cyclically Adjusted Book per Share compare to VRTX and REGN?
GlycoNex's Cyclically Adjusted Book per Share of NT$20.56 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on GlycoNex and its competitors. GlycoNex's current Cyclically Adjusted Book per Share is NT$20.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlycoNex stock overvalued right now?
Based on GuruFocus' analysis, GlycoNex (ROCO:4168) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$75.35, compared to a current price of NT$23.95 — trading 68.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$20.56. GlycoNex's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For GlycoNex (ROCO:4168), the current Cyclically Adjusted Book per Share is NT$20.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GlycoNex (ROCO:4168) Overvalued in 2026?

Based on GuruFocus' analysis, GlycoNex stock appears to be undervalued. The current stock price of NT$23.95 is trading 68.2% below its estimated GF Value™ of NT$75.35. GuruFocus considers GlycoNex to be Significantly Undervalued.

Key valuation signals for ROCO:4168:

  • Cyclically Adjusted Book per Share: NT$20.56
  • GF Value™: NT$75.35 vs. price of NT$23.95 (68.2% below fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GlycoNex Business Description

Address Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221
GlycoNex Inc is a Taiwan-based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The other services provided by the firm include functional evaluation, antibody research, and antibody engineering. It has two reportable segments: antibody new drug, which derives maximum revenue, and exclusive investment. Geographically, the group derives maximum revenue from Taiwan and the rest from Japan.
56GF Score

Get the complete analysis for ROCO:4168

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.95
Price
NT$75.35
GF Value